Does Medicare Cover Carpal Tunnel Surgery? Costs & More

Medicare carpal tunnel surgery coverage is one of the most commonly searched hand-surgery questions for a simple reason: carpal tunnel release is among the most frequently performed outpatient operations in the Medicare population, and almost everyone who needs it is surprised by how routine — and how affordable — it can be with the right coverage. Carpal tunnel syndrome affects roughly 4 to 10 percent of adults, climbs with age, and clusters heavily with conditions Medicare beneficiaries already have: diabetes, hypothyroidism, rheumatoid arthritis, and kidney disease. And carpal tunnel is only the beginning — trigger finger, Dupuytren’s contracture, and thumb arthritis form a quartet of hand conditions that hand surgeons treat in Medicare patients every day, each with its own coverage quirks.

This guide explains what Medicare pays for across the full hand and wrist pathway — nerve testing, splints, injections, surgery in each setting, Xiaflex for Dupuytren’s, and post-operative hand therapy — what you’ll owe with and without supplemental coverage, and one under-recognized red flag (carpal tunnel in both hands) that can point to a serious heart condition.

Why Hand Conditions Are Medicare-Age Conditions

The hand conditions that fill a hand surgeon’s Medicare schedule share two features: they are degenerative or metabolic in origin, and they become dramatically more common after 60.

  • Carpal tunnel syndrome (CTS) — the median nerve is compressed as it passes through the wrist, causing numbness and tingling in the thumb, index, and middle fingers, classically worse at night. It is the most common entrapment neuropathy in the body, and prevalence peaks in the 55–75 age range.
  • Trigger finger (stenosing tenosynovitis) — a finger catches or locks when bending because the flexor tendon no longer glides smoothly through its sheath. Far more common in people with diabetes, where lifetime risk runs up to 10 percent.
  • Dupuytren’s contracture — a genetically driven thickening of the tissue in the palm that slowly pulls fingers (usually the ring and small fingers) into a bent position. Typically appears after 50 and progresses over years.
  • Thumb basal joint (CMC) arthritis — arthritis at the base of the thumb, one of the most common sites of symptomatic osteoarthritis in the hand, especially in women over 60.

Several of these conditions travel together, and they travel with systemic disease. Diabetes raises the risk of carpal tunnel, trigger finger, and Dupuytren’s simultaneously. Hypothyroidism causes fluid retention in the carpal tunnel — new carpal tunnel symptoms are a recognized presentation of an underactive thyroid, which is one reason a thyroid workup is often part of the evaluation. Rheumatoid arthritis inflames the tendon linings that run through the carpal tunnel. And long-term dialysis patients develop a distinctive amyloid-related carpal tunnel syndrome — often the first sign of dialysis-related amyloidosis, covered further in our chronic kidney disease guide.

The red flag worth knowing: carpal tunnel in both hands. Bilateral carpal tunnel syndrome in an older adult — especially a man over 65, and especially when it appears alongside shortness of breath or an unexplained heart problem — is now recognized as one of the earliest warning signs of transthyretin (ATTR) cardiac amyloidosis, a progressive and treatable form of heart disease. The amyloid protein deposits in the carpal tunnel years before it deposits in the heart. If you’ve had both hands released, or both hands are symptomatic, mention it to your cardiologist or primary care physician; it changes what they look for.

Diagnosis: What Part B Covers

Medicare Part B covers the full diagnostic pathway when your physician orders it to evaluate hand symptoms. After the annual Part B deductible ($283 in 2026), you pay 20 percent coinsurance on each service.

  • Office evaluation — history and physical examination, including the classic provocative tests (Tinel’s sign, Phalen’s maneuver, carpal compression). Coinsurance typically $20–$50 per visit.
  • Electrodiagnostic testing (EMG/nerve conduction studies) — the standard objective test for carpal tunnel severity (nerve conduction CPT 95907–95913, needle EMG 95885–95887). It confirms the diagnosis, grades severity (mild, moderate, severe), and rules out mimics. Coinsurance typically $60–$150 depending on how many nerves are studied.
  • Neuromuscular ultrasound — increasingly used alongside or instead of electrodiagnostics to measure the median nerve’s cross-sectional area. Covered under Part B when ordered for diagnosis.
  • X-rays — for thumb CMC arthritis, trigger finger with suspected arthritis, or any post-traumatic complaint.

One diagnostic subtlety matters more than most patients realize: numb fingers are not always carpal tunnel. A pinched nerve in the neck (C6 or C7 cervical radiculopathy) produces overlapping symptoms, and so does peripheral neuropathy from diabetes. The EMG distinguishes these — which is why surgeons want it before operating. If your symptoms include neck pain or the numbness runs down from the shoulder, the problem may be in your spine, not your wrist; our back and spine guide covers how Medicare handles that pathway.

Conservative Treatment First

For mild and moderate carpal tunnel syndrome, guidelines support trying conservative treatment before surgery — and Medicare covers the two mainstays.

Night wrist splints are covered under Part B as durable medical equipment (a prefabricated wrist-hand orthosis) when prescribed by your physician and supplied by a Medicare-enrolled DME supplier. You pay 20 percent of the Medicare-approved amount — typically $10–$30 for an off-the-shelf splint. Worn at night, a neutral-position splint relieves symptoms in a substantial share of mild cases. (An over-the-counter drugstore splint is often nearly identical and costs $15–$40 cash — sometimes simpler than the DME paperwork, but keep the receipt as documentation of your conservative trial.)

Corticosteroid injection into the carpal tunnel (CPT 20526) is covered under Part B. Coinsurance typically runs $15–$40 in an office setting. Injections often produce weeks to months of relief; the catch is that relief from an injection is also a strong predictor that surgery will work, so many surgeons use it as both treatment and diagnostic confirmation. For trigger finger, a tendon-sheath injection (CPT 20550) is the standard first-line treatment and resolves the problem permanently in roughly half of cases — more in mild cases, fewer in diabetics.

There is no Medicare requirement to fail conservative treatment for a fixed period before carpal tunnel surgery — unlike, say, varicose vein procedures. But for severe carpal tunnel (constant numbness, thumb muscle wasting, marked EMG changes), delay has a real cost: compression that persists too long can cause permanent nerve damage that surgery cannot fully reverse. Severe disease is a reason to move directly to surgery, and Medicare covers it that way.

Carpal Tunnel Release: Coverage and Costs by Setting

Carpal tunnel release — cutting the ligament that forms the roof of the carpal tunnel to give the nerve room — is a brief, definitive operation with success rates above 90 percent. Medicare covers it under Part B whether performed open (CPT 64721, through a small palm incision) or endoscopically (CPT 29848, through a camera portal). Neither approach is “better” for coverage purposes; both are fully covered, and long-term outcomes are equivalent.

What changes your cost is where the procedure is done:

  • Office-based release under local anesthetic (WALANT — “wide awake, local anesthesia, no tourniquet”): a growing share of releases are done in the surgeon’s procedure room with only lidocaine, no sedation, no anesthesiologist, no facility. This is the least expensive setting — total Medicare-approved amounts are lowest, and your 20 percent coinsurance may run $100–$250.
  • Ambulatory surgery center (ASC): the most common setting. Surgeon fee plus ASC facility fee; coinsurance typically $200–$450 all-in.
  • Hospital outpatient department (HOPD): the same operation with a hospital facility fee attached; coinsurance commonly $400–$900.

The operation itself is identical in all three settings. If your surgeon operates in more than one location, asking “what would this cost at the surgery center instead of the hospital?” is one of the highest-yield questions in this article.

Both hands? About half of carpal tunnel patients eventually need both sides released. Surgeons usually stage the two operations weeks apart (you need one working hand), and each stage generates its own coinsurance. Some surgeons offer simultaneous bilateral release for the right candidate — one anesthetic event, one recovery, and one round of facility fees rather than two.

Trigger Finger, Dupuytren’s, and Thumb Arthritis

Trigger finger release

When injections fail or the finger locks, trigger finger release (CPT 26055) is a five-minute operation through a tiny palm incision, covered under Part B in office, ASC, or HOPD settings. Coinsurance typically $100–$300 depending on setting. It is common for Medicare patients — particularly diabetics — to need more than one finger released over time; each finger is billed separately.

Dupuytren’s contracture: three covered paths

Medicare covers Dupuytren’s treatment when the contracture is functionally significant — most contractors and surgeons use the benchmarks of a 30-degree bend at the knuckle (MCP joint) or any established contracture at the middle joint (PIP), or a positive “tabletop test” (you can no longer flatten your palm on a table). Observation is correct for early, non-contracted disease: no treatment slows progression, so nothing is gained by intervening on a painless nodule.

  1. Needle aponeurotomy (CPT 26040) — the cord is weakened and snapped through needle punctures under local anesthetic in the office. Least invasive, fastest recovery, highest recurrence. Coinsurance often $50–$150.
  2. Collagenase injection (Xiaflex) — an enzyme injected into the cord dissolves it; the finger is straightened at a follow-up visit a day or two later. Xiaflex is a Part B drug, not Part D — it’s administered by the physician, so it falls on the Part B side of the drug coverage divide. The drug alone lists at roughly $4,000–$6,000 per injection; 20 percent coinsurance means $800–$1,200+ per treated cord without supplemental coverage — the single most expensive line item in outpatient hand care, and a place where Medigap pays for itself in one visit.
  3. Limited fasciectomy (CPT 26123) — surgical removal of the diseased cord, the most durable option for advanced or recurrent contracture. Outpatient under Part B; coinsurance typically $400–$900 including facility fees, plus post-operative hand therapy.

Thumb basal joint arthritis

Thumb CMC arthritis follows the standard osteoarthritis pathway — activity modification, a thumb spica splint (covered as DME, like the wrist splint), and corticosteroid injections (covered under Part B), all covered along the same lines described in our osteoarthritis conservative-management guide. When conservative care fails, CMC arthroplasty (removing the arthritic trapezium bone, CPT 25447) is covered under Part B as an outpatient procedure; coinsurance typically runs $500–$1,000 with facility fees, and recovery includes several weeks of splinting and therapy.

Hand Therapy After Surgery

Post-operative hand therapy — usually with an occupational therapist certified in hand therapy — is covered under Part B outpatient therapy with no hard annual cap (the old “therapy cap” was repealed in 2018; above an annual threshold your therapist simply documents continued medical necessity). You pay 20 percent coinsurance per session, typically $15–$40.

Most carpal tunnel and trigger finger patients need little or no formal therapy. Dupuytren’s fasciectomy and CMC arthroplasty patients usually need six to twelve weeks of it — often including a custom-fabricated orthosis (splint), which is also covered under Part B. Budget for therapy when you’re pricing those procedures; ten sessions of coinsurance adds $150–$400 to the true cost of the operation.

What You’ll Pay: Cost Summary

ServiceCoverageTypical 20% coinsurance*With Medigap Plan G
EMG/nerve conduction studyPart B$60–$150$0
Night wrist splint (DME)Part B$10–$30$0
Carpal tunnel / trigger finger injectionPart B$15–$40$0
Carpal tunnel release (office/WALANT)Part B$100–$250$0
Carpal tunnel release (ASC)Part B$200–$450$0
Carpal tunnel release (hospital outpatient)Part B$400–$900$0
Trigger finger releasePart B$100–$300$0
Xiaflex injection (drug + procedure)Part B$800–$1,300$0
Dupuytren’s fasciectomyPart B$400–$900$0
Thumb CMC arthroplastyPart B$500–$1,000$0
Hand therapy (per session)Part B$15–$40$0

*After the $283 annual Part B deductible (2026). Hospital outpatient settings add facility fees at the higher end of each range.

With Medigap Plan G, every service in this table costs $0 after the annual deductible — which is why patients facing a multi-procedure year (both hands, several trigger fingers, a Xiaflex series) should read our Medigap versus Medicare Advantage cost comparison before, not after, the surgical consultation. If your income is limited, a Medicare Savings Program can cover the Part B deductible and coinsurance entirely.

Medicare Advantage: Prior Authorization and Network Realities

Medicare Advantage plans must cover everything Original Medicare covers, but elective hand surgery sits squarely in prior-authorization territory for most plans. Expect the plan to require the EMG results and documentation of conservative treatment before approving a release — even though Original Medicare imposes no such waiting period. Xiaflex frequently requires its own drug-specific prior authorization, and some plans steer patients toward fasciectomy or needle aponeurotomy first.

Network design matters too: fellowship-trained hand surgeons are concentrated in larger groups and academic centers, and HMO plans require referrals and in-network surgeons. None of this makes hand surgery unreachable in Medicare Advantage — copays for outpatient surgery are often reasonable — but it adds steps and weeks. If you’re comparing coverage while a hand problem is active, factor in the authorization timeline, not just the copay table.

Seven Steps to Getting Hand Surgery Covered Smoothly

  1. Start with your primary care physician — document the symptoms, get the referral, and rule out mimics (thyroid, diabetes control, neck).
  2. Get the EMG before scheduling surgery — it confirms the diagnosis, grades severity, and pre-empts both surgical surprises and Medicare Advantage authorization denials.
  3. Try the covered conservative steps for mild disease — a night splint and an injection may end the problem, and the documentation helps if surgery follows.
  4. Don’t wait on severe symptoms — constant numbness or visible thumb-muscle wasting means the nerve is dying; surgery sooner protects what’s left.
  5. Ask about the setting — office-based (WALANT) or ASC release can cut your out-of-pocket cost by half or more versus a hospital outpatient department.
  6. Price the whole pathway — both hands, multiple trigger fingers, Xiaflex plus follow-up, therapy sessions. Recurring-procedure years are where supplemental coverage decisions pay off.
  7. Mention bilateral carpal tunnel to your doctor — especially with any heart symptoms; it’s an early amyloidosis clue that’s easy to act on and easy to miss.

Frequently Asked Questions

Does Medicare cover carpal tunnel surgery? Yes. Carpal tunnel release — open or endoscopic — is covered under Medicare Part B as an outpatient procedure when you have a confirmed diagnosis. You pay 20 percent coinsurance after the $283 annual deductible; Medigap covers that coinsurance in full.

Do I need to fail splints and injections before Medicare will pay for surgery? No — Original Medicare has no mandatory conservative-treatment period for carpal tunnel release. Severe disease can and should go straight to surgery. Medicare Advantage plans, however, often require documented conservative treatment through prior authorization.

How much does carpal tunnel surgery cost with Medicare? Typically $100–$250 in an office setting, $200–$450 at an ambulatory surgery center, and $400–$900 in a hospital outpatient department — the same operation at three price points. With Medigap Plan G, $0 after the annual deductible.

Is Xiaflex for Dupuytren’s contracture covered by Medicare? Yes, as a Part B drug, because it’s injected by your physician. The 20 percent coinsurance on the drug plus the procedure commonly reaches $800–$1,300 per treated cord without supplemental coverage, so confirm your Medigap or Advantage plan details first.

Does Medicare cover hand therapy after surgery? Yes — outpatient occupational/hand therapy is covered under Part B with no hard annual cap, at 20 percent coinsurance per session. Custom post-surgical splints made by the therapist are covered too.

Why does my doctor care that I had carpal tunnel in both hands? Bilateral carpal tunnel syndrome in older adults is a recognized early warning sign of transthyretin (ATTR) cardiac amyloidosis — the amyloid protein deposits in the wrists years before the heart. It doesn’t mean you have it; it means it’s worth screening for, especially with unexplained heart failure symptoms.

Hand surgery is some of the most cost-effective, highest-satisfaction care in Medicare — brief procedures, local anesthesia, decades of restored function. The coverage is genuinely good; the variable is what you pay out of pocket, and that’s determined almost entirely by your supplemental coverage and the setting you choose. Ten minutes of asking the right questions before the operation is usually worth several hundred dollars after it.